North American Spending on Electronic Health Records Through 2012 (Databook)
| Publication Date | November 2007 |
|---|---|
| Publisher | Datamonitor |
| Product Type | Report |
| Pages | 14 |
| ISBN Number | not applicable |
| Product Code | DAT08355 |
Summary
Introduction
Electronic health records (EHRs) will be the cornerstone of healthcare technology. The design, selection and implementation of EHRs, therefore, will be extremely important for healthcare institutions.
Scope
- Identifies potential growth areas for the EHR market
- Quantifies spending on EHRs by application
- Segments EHR spending by geography and technology
Highlights
The uptake of EHRs will increase rapidly in the next five years and will continue to increase after 2012.
Datamonitor expects Software as a Service to become more prevalent in the EHR market.
Reasons to Purchase
- Understand the current and future direction of EHR investment
- Compare opportunities across countries and market segments
Content
- Overview
- Catalyst
- Summary
- Methodology
- Introduction
- North American Spending On Ehrs Through 2012
- Spending On Ehrs In The Us Through 2012
- Ambulatory Spending On Ehrs In The Us Through 2012
- Hospital Spending On Ehrs In The Us Through 2012
- Spending On Ehrs In Canada Through 2012
- Ambulatory Spending On Ehrs In Canada Through 2012
- Hospital Spending On Ehrs In Canada Through 2012
- Appendix
- Definitions
- Further Reading
- Ask The Analyst
- Datamonitor Consulting
- Disclaimer
- Figure 1: North American Spending On Ehrs Through 2012 (Million Us$)
- Figure 2: Spending On Ehrs In The Us Through 2012 (Million Us$)
- Figure 3: Ambulatory Spending On Ehrs In The Us Through 2012 (Million Us$)
- Figure 4: Hospital Spending On Ehrs In The Us Through 2012 (Million Us$)
- Figure 5: Spending On Ehrs In Canada Through 2012 (Million Us$)
- Figure 6: Ambulatory Spending On Ehrs In Canada Through 2012 (Million Us$)
- Figure 7: Hospital Spending On Ehrs In Canada Through 2012 (Million Us$)
- Table 1: North American Spending On Ehrs Through 2012 (Million Us$)
- Table 2: Spending On Ehrs In The Us Through 2012 (Million Us$)
- Table 3: Ambulatory Spending On Ehrs In The Us Through 2012 (Million Us$)
- Table 4: Hospital Spending On Ehrs In The Us Through 2012 (Million Us$)
- Table 5: Spending On Ehrs In Canada Through 2012 (Million Us$)
- Table 6: Ambulatory Spending On Ehrs In Canada Through 2012 (Million Us$)
- Table 7: Hospital Spending On Ehrs In Canada Through 2012 (Million Us$)
About this Product
Delivery Details
PDF:Delivered by email usually within 4 to 8 UK business hours.
PRINT/CD-ROM:Despatched within 1 to 2 working days.
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















